Jeffrey Sachs, a Harvard economist, has drawn attention to the scale of the problem: poor countries cannot afford expensive medicines, and drug companies naturally tend to focus their research on finding cures for the ills of the rich (see Jeffrey Sachs on development and Medicines for poor countries) rather than the afflictions of the poor.